Abstract: The present invention relates to the innovation that ECFCs are a predictor of the likely result to the exposure of a patient to low dose ionizing radiation by comparing the results of exposure of cells to individuals already exposed to ECFCs.
Type:
Grant
Filed:
January 28, 2014
Date of Patent:
July 18, 2017
Assignee:
Creative Scientist, Inc.
Inventors:
Alexander V Kinev, Dora Il'yasova, Mark W. Dewhirst